Dysregulation of Dopamine Systems in a Developmental Disruption Model of Schizophrenia: Implications for Pathophysiology, Treatment, and Prevention

Sofia M. Dibble, Yijuan Du, Anthony A. Grace

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

Clinical observations, postmortem work, and neuroimaging have fostered hypotheses on the etiology, pathology, psychology, and progression of schizophrenia. However, animal models are indispensable tools for testing and expanding these hypotheses rigorously. Here we review the methylazoxymethanol (MAM)-17 neurodevelopmental animal model of schizophrenia in which gross brain abnormalities observed in schizophrenia can be reliably mimicked by exposure to MAM in the rat on gestational day 17. In establishing the validity of this model, we summarize the rationale for approaching schizophrenia as a neurodevelopmental disorder, for using the MAM compound, and the schizophrenia-like abnormalities that the model reproduces. Work in this model has already led to the generation of unifying hypotheses on network dysfunction in schizophrenia, especially the relationship between anomalous hippocampal activity and dopamine dysregulation. Looking forward, the MAM-17 is an important animal model in which the critical neurodevelopmental events underlying the adolescent onset of this disorder may be elucidated and novel treatments may be tested and compared with currently available antipsychotics.

Original languageEnglish (US)
Title of host publicationHandbook of Behavioral Neuroscience
PublisherElsevier B.V.
Pages107-124
Number of pages18
DOIs
StatePublished - 2016
Externally publishedYes

Publication series

NameHandbook of Behavioral Neuroscience
Volume23
ISSN (Print)1569-7339

Keywords

  • Adolescence
  • Animal model
  • Antipsychotics
  • Dopamine
  • Hippocampus
  • MAM
  • Methylazoxymethanol
  • Neurodevelopmental
  • Parvalbumin
  • Schizophrenia
  • VTA

Fingerprint Dive into the research topics of 'Dysregulation of Dopamine Systems in a Developmental Disruption Model of Schizophrenia: Implications for Pathophysiology, Treatment, and Prevention'. Together they form a unique fingerprint.

  • Cite this

    Dibble, S. M., Du, Y., & Grace, A. A. (2016). Dysregulation of Dopamine Systems in a Developmental Disruption Model of Schizophrenia: Implications for Pathophysiology, Treatment, and Prevention. In Handbook of Behavioral Neuroscience (pp. 107-124). (Handbook of Behavioral Neuroscience; Vol. 23). Elsevier B.V.. https://doi.org/10.1016/B978-0-12-800981-9.00008-0